State Street Corp Vanda Pharmaceuticals Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 1,165,182 shares of VNDA stock, worth $5.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,165,182
Previous 1,211,309 3.81%
Holding current value
$5.76 Million
Previous $6.84 Million 20.15%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.61 - $6.34 $212,645 - $292,445
-46,127 Reduced 3.81%
1,165,182 $5.46 Million
Q2 2024

Aug 14, 2024
BUY
$3.91 - $6.5 $31,334 - $52,091
8,014 Added 0.67%
1,211,309 $6.84 Million
Q1 2024

May 15, 2024
SELL
$3.47 - $4.61 $86,059 - $114,332
-24,801 Reduced 2.02%
1,203,295 $4.95 Million
Q4 2023

Feb 14, 2024
SELL
$3.38 - $4.58 $255,815 - $346,637
-75,685 Reduced 5.81%
1,228,096 $5.18 Million
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $11.9 Million - $18.2 Million
-2,776,855 Reduced 68.05%
1,303,781 $5.63 Million
Q2 2023

Aug 14, 2023
SELL
$5.9 - $6.95 $2.78 Million - $3.28 Million
-471,276 Reduced 10.35%
4,080,636 $26.9 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $5.09 Million - $6.58 Million
824,114 Added 22.11%
4,551,912 $30.9 Million
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $291,610 - $465,219
42,447 Added 1.15%
3,727,798 $27.5 Million
Q3 2022

Nov 15, 2022
SELL
$9.44 - $11.76 $288,618 - $359,550
-30,574 Reduced 0.82%
3,685,351 $36.4 Million
Q2 2022

Aug 15, 2022
SELL
$9.31 - $11.84 $3.23 Million - $4.11 Million
-347,373 Reduced 8.55%
3,715,925 $40.5 Million
Q1 2022

May 16, 2022
BUY
$10.84 - $16.55 $7.98 Million - $12.2 Million
735,865 Added 22.12%
4,063,298 $46 Million
Q4 2021

Feb 14, 2022
SELL
$15.69 - $21.14 $1.11 Million - $1.49 Million
-70,609 Reduced 2.08%
3,327,433 $52.2 Million
Q3 2021

Nov 15, 2021
BUY
$15.35 - $21.27 $3.63 Million - $5.03 Million
236,533 Added 7.48%
3,398,042 $58.2 Million
Q2 2021

Aug 16, 2021
SELL
$15.71 - $21.51 $2.37 Million - $3.24 Million
-150,830 Reduced 4.55%
3,161,509 $68 Million
Q1 2021

May 17, 2021
BUY
$13.42 - $20.28 $1.46 Million - $2.2 Million
108,435 Added 3.38%
3,312,339 $49.8 Million
Q4 2020

Feb 16, 2021
SELL
$9.77 - $13.81 $1.77 Million - $2.51 Million
-181,430 Reduced 5.36%
3,203,904 $42.1 Million
Q3 2020

Nov 10, 2020
SELL
$9.32 - $12.02 $2.73 Million - $3.53 Million
-293,278 Reduced 7.97%
3,385,334 $32.7 Million
Q2 2020

Aug 14, 2020
BUY
$9.66 - $12.02 $8.14 Million - $10.1 Million
842,696 Added 29.72%
3,678,612 $42.1 Million
Q1 2020

May 11, 2020
BUY
$7.5 - $16.8 $21.3 Million - $47.6 Million
2,835,916 New
2,835,916 $29.4 Million

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $279M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email